Global Drug Discovery Outsourcing Market- Market Overview:

The Global Drug Discovery Outsourcing market is expected to grow from USD 3 billion in 2021 to USD 5.55 billion by 2029, at a CAGR of 8% during the Projection period 2022-2029. The growth of this market is mainly driven owing to increasing development in the healthcare sector.

The pharmaceutical industry faces numerous challenges as it is getting more expensive to develop new drugs, competition from generics is increasing, investors expect double-digit growth, complaints from consumers and payors (including the federal government) about excessive drug prices are more stringent, and the number of new drugs reaching the market each year is below expectations. Breaking down the different steps of drug discovery, such as hit confirmation, lead generation, lead optimization, and high-speed screening, allows players to specialize in their core services. An estimated 75.0% to 80.0% of R&D spending in the biopharmaceutical industry can be outsourced, creating opportunities for Contract Research Organizations (CROs), which, in turn, is expected to boost the market growth. Pharmaceutical companies are partnering with manufacturing facilities in developing countries, backed by skilled manpower, low cost, and quality data. Cost-cutting, chasing innovation, gaining access to specialized knowledge and technology, and increasing speed and agility are significant factors encouraging pharma companies to expand the level of outsourcing. Moreover, the development and testing phases of the drug pipeline are no stranger to outsourcing solutions. Contract research is a maturing industry sector, and there are more than 1,000 CROs in the U.S. and Europe. The top 10 accounts for approximately 40% of industry sales. However, CROs have been focused on drug development and clinical trial support, where they can effectively speed drugs to market. Earlier stages of the pipeline—drug discovery and various preclinical development tasks—have not traditionally been outsourced. This is changing.

Sample Request: - Global Drug Discovery Outsourcing Market

Market Dynamics:

Drivers:                          

• Increasing R&D spending by pharmaceutical and biotechnology businesses

Most pharmaceutical, biopharmaceutical, and medical device businesses invest significantly in creating new medications and equipment. The pharmaceutical sector invests much in R&D. Pharmaceutical businesses spend on R&D to bring the market cutting-edge, high-quality goods. According to trends, the leading pharmaceutical companies are enhancing their R&D productivity through significant long-term investments in R&D and joint R&D projects. Pharmaceutical and biopharmaceutical businesses choose fully integrated or functional outsourcing services for drug research and development from early to late-stage development due to increased R&D expenditures. As pharmaceutical businesses are under intense pressure to control fixed costs, outsourcing has emerged as a tactical solution to the lack of internal resources needed for new product development. Big pharma firms are switching to a leaner corporate strategy that strongly emphasises outsourcing.

Restraints:                                             

• Strict guidelines for using animals in medicine development and another field

Regulatory agencies' main priorities are safety and efficacy during the drug approval process. Although these strategies aid in ensuring the quality of products introduced to the market, they significantly raise the price of developing new drugs and the cost of the finished product. This aspect can considerably impact the uptake of a certain treatment in emerging markets that are price sensitive. In addition, many laws that guarantee the quality of the product (like GMP) frequently raise manufacturing expenses. Strict regulations govern the use of animals in the drug discovery process. The most often employed animals in the study are mice, rats, fish, amphibians, and reptiles. Governments have introduced rules for animal safety and use in response to ethical questions about this practice, which poses several difficulties for drug discovery research. Due to this, businesses are now using alternative methods to reduce the use of animals. For instance, Novo Nordisk uses biosimulation, simulating human biology using computer models. However, the industry as a whole has not yet fully embraced this.

Opportunities:

• There is a tremendous amount of demand from small and medium-sized businesses.

Companies in the biotech and pharmaceutical industries, particularly SMEs, have shown a strong interest in outsourcing drug discovery. The value chain of the drug discovery outsourcing market will be enriched by an increase in the number of small and medium-sized firms that are leaning toward outsourcing various stages of the drug discovery process. Simple organizational structures of SMEs and a general lack of technical skills are important drivers of demand that will improve the outlook for the drug discovery outsourcing market.

Challenges

• Lack of Qualified Personnel

The R&D outsourcing market for pharmaceuticals, biotechnology, and medical devices is always changing. Professionals must deliver excellent services, adhere to proper laboratory practices, and stay up with the ongoing developments in pharmaceutical R&D technologies and processes. As they compete for competent and experienced scientists with pharmaceutical and biotechnology corporations, academic institutions, and research organizations, CROs confront difficulties in attracting and keeping highly skilled personnel. Companies must give larger salaries and other perks to compete successfully; this could have an impact on the finances and business performance of competitors, particularly small-scale analytical testing suppliers. Adopting new technologies and procedures may be hampered by this talent gap, which could limit the market for drug discovery services in the years to come.

Segmentation Analysis:

The global drug discovery outsourcing market has been segmented based on drug type, therapeutic area, workflow, and region.

By Drug Type

The drug type includes small and large molecules. The small molecule segment led the drug discovery outsourcing market with a market share of around 68% in 2021. Small molecules are crucial in the creation of novel medicines for patients all over the world. Small molecule applications account for sales of fifty per cent of speciality medications. Additionally, it can be seen in the current approval trends. The FDA authorized 48 new medications in 2019, 79% made up of small molecules. Oncology, cardiovascular, autoimmune, and respiratory disorders are four important therapeutic areas where small molecules play a critical role in developing new medicines.

By Therapeutic Area

The therapeutic area includes the respiratory system, oncology, immunomodulation, and others. The respiratory system segment led the drug discovery outsourcing market with a market share of around 41% in 2021. Growth in this market has been impacted by the high prevalence of respiratory diseases such as bronchitis, TB, chronic obstructive pulmonary disease (COPD), asthma, and rising medication resistance instances. Additionally, it has been determined that the advent of innovative drug administration techniques, including nasal sprays, is a major driver of category revenue. In the United Kingdom, lung diseases account for more than 6 million inpatient bed days and over 700,000 hospital admissions annually. In the UK, an estimated 1.2 million people have COPD that has been diagnosed. In light of this, The University of Nottingham, GSK, and the University of Leicester established a strategic research partnership in 2018. The partnership aims to hasten the research and creation of cutting-edge COPD medicines.

By Workflow

The workflow includes target identification & screening, target validation & functional informatics, lead identification & candidate optimization, and others. The lead identification & candidate optimization segment led the drug discovery outsourcing market with a market share of around 41% in 2021. An important phase of early drug discovery is the iterative process of lead identification, commonly referred to as hit-to-lead. It has a history of helping medication developers achieve greater economies of scale and efficiency. Segment expansion is supported by introducing cutting-edge in silico methods to enhance the lead identification procedure, such as Computer-Aided Drug Discovery (CADD) and structure-based drug designs. Increased outsourcing of lead identification services is made possible by the growing demand for professional workers who combine knowledge of analytical chemistry, metabolism, and computer software with the expensive expense of integrating the most cutting-edge computing technologies. Lead discovery and candidate optimization thus accounted for the majority of the total share.

By Regional Analysis:

The regions analyzed for the Drug Discovery Outsourcing market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North America region dominated the Drug Discovery Outsourcing market and held a 40% share of the market revenue in 2021.

• North America region witnessed a major share. The growth in pandemic focus and the consequent outsourcing of drug discovery to businesses with AI technology are both factors that have contributed to the expansion of the drug discovery outsourcing market in the area. The industry is also fueled by larger pharmaceutical and biotechnology businesses investing more money in R&D and their focus on reducing internal costs, which has resulted in the outsourcing of the drug discovery process.
• Asia Pacific is anticipated to experience significant growth during the predicted period. Due to the availability of trained labor, cheaper costs, a supportive regulatory framework, and high-quality data, the area is quickly becoming a center for outsourcing drug discovery activities. Additionally, Japan, the second-largest pharmaceutical market in the world, is anticipated to offer CROs a significant opportunity, propelling the market. The amended Pharmaceutical Affairs Law encourages research on cancer and tissue diagnostics in Japan, which is anticipated to stimulate market expansion in that nation.

Global Drug Discovery Outsourcing Market- Country Analysis:

• Germany

Germany's Drug Discovery Outsourcing market size was valued at USD 0.23 billion in 2021 and is expected to reach USD 0.36 billion by 2029, at a CAGR of 6% from 2022 to 2029. The pharmaceutical sector is seeing rising investments in Germany. Additionally, 499 clinical studies were funded by research-based pharmaceutical businesses in 2019. 640 biologics were being developed by pharma R&D businesses at the same time, 82% of which were Phase III assets and new biological entities. The development of biologicals places a high priority on oncology, immunology, and infectious disorders. As a result of these advancements, there is an increase in demand for outsourcing drug discovery.

• China

China Drug Discovery Outsourcing’s market size was valued at USD 0.30 billion in 2021 and is expected to reach USD 0.52 billion by 2029, at a CAGR of 7.2% from 2022 to 2029. Drug discovery outsourcing sales in China have increased as a result of changing consumer lifestyles, rising baby gear awareness, simple accessibility, and rising per capita income. All of them encourage parents to purchase baby gear, regardless of cost. Additionally, with the intention of buying high-quality products for their newborns, consumers' preferences have switched more toward those made by organized businesses, which has boosted the industry. After the advent of new multinational players, this industry saw significant upheaval.

• India

India's Drug Discovery Outsourcing market size was valued at USD 0.26 billion in 2021 and is expected to reach USD 0.43 billion by 2029, at a CAGR of 6.6% from 2022 to 2029. The outsourcing of drug discovery to India is about to get a huge boost as pharmaceutical corporations increase their R&D efforts with the support of the major key players. From the perspective of market demand, factors such as sound economic growth (and correspondingly rising per capita income), rise in diagnosis and treatment rates, growth in chronic illnesses with changing lifestyles as a result of economic growth, and growth in chronic ailments are driving the growth in the pharmaceutical market which fuels the need for outsourcing.

Key Industry Players Analysis:                                                     

To increase their market position in the global Drug Discovery Outsourcing business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.

• Albany Molecular Research Inc.
• WuXi AppTec
• EVOTEC
• Jubilant Biosys
• GenScript
• Pharmaceutical Product Development, LLC
• Charles River
• Laboratory Corporation of America Holdings
• Merck & Co., Inc.
• Thermo Fisher Scientific Inc.
• Dalton Pharma Services
• Oncodesign
• Pharmaron Beijing Co., Ltd.
• TCG Lifesciences Pvt Ltd.
• Eurofins SE
• Domainex Ltd.
• DiscoverX Corp.
• QIAGEN
• Syngene International Limited
• Reddy Laboratories Ltd.

Latest Development:

• In February 2020, Citoxlab was bought by Charles River for US$ 510 million. Citoxlab is a non-clinical CRO that specializes in medical device testing, non-regulated discovery services, and regulated safety assessment services.
• In July 2020, A renowned CRO with an Indian origin, Syngene International Ltd., expanded its R&D partnership with Baxter Healthcare Corporation in July 2020.

Report Metrics

Report Attribute	Details
Study Period	2021-2029
Base year	2021
CAGR (%)	8%
Market Size	3 billion in 2021
Projection period	2022-2029
Projection unit	Value (USD)
Segments covered	By Drug Type, By Therapeutic Area, By Workflow, and Region.
Report Scope	Revenue Projection, competitive landscape, company ranking, growth factors, and trends
Companies covered	Albany Molecular Research Inc., WuXi AppTec, EVOTEC, Jubilant Biosys, GenScript, Pharmaceutical Product Development, LLC, Charles River, Laboratory Corporation of America Holdings, Merck & Co., Inc., Thermo Fisher Scientific Inc., Dalton Pharma Services, Oncodesign, Pharmaron Beijing Co., Ltd., TCG Lifesciences Pvt Ltd., Eurofins SE, Domainex Ltd., DiscoverX Corp., QIAGEN, Syngene International Limited, Dr. Reddy Laboratories Ltd., among others
By Drug Type	Small Large Molecules
By Therapeutic Area	Respiratory System Oncology Immunomodulation Others
By Workflow	Target Identification & Screening Target Validation & Functional Informatics Lead Identification & Candidate Optimization Others
Regional scope	North America Europe Asia-Pacific South America Middle East and Africa

Scope of the Report

Global Drug Discovery Outsourcing Market by Drug Type:

• Small
• Large Molecules

Global Drug Discovery Outsourcing Market by Therapeutic Area:

• Respiratory System
• Oncology
• Immunomodulation
• Others

Global Drug Discovery Outsourcing Market by Workflow:

• Target Identification & Screening
• Target Validation & Functional Informatics
• Lead Identification & Candidate Optimization
• Others

Global Drug Discovery Outsourcing Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
• Asia-Pacific
  • Japan
  • China
  • India
  • Korea
  • Southeast Asia
• South America
  • Brazil
  • Peru
• Middle East and Africa
  • UAE
  • South Africa
  • Saudi Arabia

Political Factors- Politics in this arena has a direct impact on healthcare expenses. These include adjustments to insurance laws and medical practices. Consider the Medicare and Medicaid programmes, along with government expenditures and hiring practises. The political environment's impact on how the healthcare sector operates is always changing, especially as a result of changing governmental regulations that have an impact on outsourcing drug research. Many economies have taken action to cut back on spending in the health sector globally. Political factors, such as changing tax legislation, employment limits, consumer protection laws, and insurance requirements, may have an impact on the healthcare industry. Additionally, strikes by medical professionals over wage disparities and modifications to legislation governing the import of medicines are inherently political issues that have an impact on healthcare practitioners. Changes in tax law have a big impact on how much money the government spends on healthcare.

Economical Factors- When focusing on the economic ramifications, take into account how unemployment and inflation affect people's capacity to pay for insurance and medical expenses. Therefore, these traits directly affect the drug discovery outsourcing market by influencing how successfully healthcare organisations and other enterprises engaged in the field work. Unemployment, interest rates, the accessibility of loans, and inflation are a few examples of economic factors that have an impact on the functionality and operation of technology in the healthcare industry. The spending decisions of firms and consumer purchase habits may be strongly impacted by these changes in the economy. For instance, a significant number of investors in the healthcare sector may be let down by rising interest rates. In a manner similar, escalating unemployment or dwindling consumer spending power would suggest that they would not utilise the products or services offered by healthcare manufacturers. It makes sense to identify the infrastructures that improve medical services and increase industrial investment.

Social Factor- The use of health technology services by individuals has a significant impact on their cultural beliefs and values. Particularly in some societies, traditional techniques are preferred. Others seek out alternative medical treatments or natural cures. Socio-cultural factors focus on the opinions, attitudes, and norms of a certain clientele group as well as issues like gender preference, population ageing, and declining fertility. Businesses must comprehend the culture of their clients in order to avoid compromising their values and views. For example, more and more people are turning to natural remedies to cure conditions like fever, the flu, and headaches. By understanding the justification behind this approach, healthcare professionals can provide these patients with better treatment.

Technological Factors- Costs may be incurred by drug discovery outsourcing companies as a result of the creation of cutting-edge technology solutions. Outsourcing of drug discovery is directly impacted by the cost of healthcare. Healthcare facilities also need to focus on teaching staff members how to use modern technology. Medical firms engage in two activities: healthcare distribution and technological solutions. For instance, the development of drugs for Covid-19 has a great impact on saving the mankind and was very much helpful in the most critical condition. Most of the countries outsourced the drug from India or other countries whose Covid-19 drug was more effective. The adoption of technological healthcare solutions can be encouraged by using improvements in technology as marketing strategies. In fact, technology advancements present healthcare organisations with enormous growth opportunities.

Environmental Factors- Drug discovery outsourcing organizations must look into the waste disposable procedures very minutely and help in the protection of the environment. The goal is to address the population's environmental concerns in particular and look for ways to reduce the pollution and save the environment. They should therefore include such initiatives in their strategic planning as a result. The fundamental purpose of healthcare is undercut by the way the system degrades the environment in ways that also harm health. For instance, the health care sector contributes significantly to the world's emissions of greenhouse gases, dangerous particulate matter (air particles), nitrogen oxides, and sulphur dioxide, which total 4.4%, 2.8%, 3.4%, and 4.6%, respectively.

Legal Factors- Since they are crucial in relation to corporations that outsource drug discovery, the legal section must be considered. The latter in particular should follow the laws that govern the industry. Important subjects like labour law, consumer protection, organ donation, health insurance, medical abortion, pre-conception, and prenatal diagnosis are discussed. Patients are meant to be protected by healthcare law from mistakes, fraud, and system abuse. It also protects their legal rights, particularly their right to privacy. Remind one of their duty and rights: The limits of one's job are set by laws governing healthcare.

1. Introduction
   • 1. Objectives of the Study
   • 2. Market Definition
   • 3. Research Scope
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
   • 1. Porter’s Five Forces Analysis
   • 2. Value Chain Analysis
   • 3. Top Investment Pockets
     • 3.1. Market Attractiveness Analysis By Drug Type
     • 3.2. Market Attractiveness Analysis By Therapeutic Area
     • 3.3. Market Attractiveness Analysis By Workflow
     • 3.4. Market Attractiveness Analysis By Region
   • 4. Industry Trends
5. Market Dynamics
   • 1. Market Evaluation
   • 2. Drivers
     • 2.1. Increasing R&D spending by Respiratory System and biotechnology businesses
   • 3. Restraints
     • 3.1. Strict guidelines for using animals in medicine development and other fields
   • 4. Opportunities
     • 4.1. There is a tremendous amount of demand from small and medium-sized businesses.
   • 5. Challenges
     • 5.1. Lack of qualified personnel

6. Global Drug Discovery Outsourcing Market Analysis and Projection, By Drug Type
   • 1. Segment Overview
   • 2. Small Molecules
   • 3. Large Molecules
7. Global Drug Discovery Outsourcing Market Analysis and Projection, By Therapeutic Area
   • 1. Segment Overview
   • 2. Respiratory System
   • 3. Oncology
   • 4. Immunomodulation
   • 5. Others
8. Global Drug Discovery Outsourcing Market Analysis and Projection, By Workflow
   • 1. Segment Overview
   • 2. Target Identification & Screening
   • 3. Target Validation & Functional Informatics
   • 4. Lead Identification & Candidate Optimization
   • 5. Others
9. Global Drug Discovery Outsourcing Market Analysis and Projection, By Regional Analysis
   • 1. Segment Overview
   • 2. North America
     • 2.1. U.S.
     • 2.2. Canada
     • 2.3. Mexico
   • 3. Europe
     • 3.1. Germany
     • 3.2. France
     • 3.3. U.K.
     • 3.4. Italy
     • 3.5. Spain
   • 4. Asia-Pacific
     • 4.1. Japan
     • 4.2. China
     • 4.3. India
   • 5. South America
     • 5.1. Brazil
   • 6. Middle East and Africa
     • 6.1. UAE
     • 6.2. South Africa

10. Global Drug Discovery Outsourcing Market-Competitive Landscape
    • Overview
    • Market Share of Key Players in the Drug Discovery Outsourcing Market
      • 2.1. Global Company Market Share
      • 2.2. North America Company Market Share
      • 2.3. Europe Company Market Share
      • 2.4. APAC Company Market Share
    • Competitive Situations and Trends
      • 3.1. Product Launches and Developments
      • 3.2. Partnerships, Collaborations, and Agreements
      • 3.3. Mergers & Acquisitions
      • 3.4. Expansions

11. Company Profiles
    • Albany Molecular Research Inc.
      • 1.1. Business Overview
      • 1.2. Company Snapshot
      • 1.3. Company Market Share Analysis
      • 1.4. Company Product Portfolio
      • 1.5. Recent Developments
      • 1.6. SWOT Analysis
    • WuXi AppTec
      • 2.1. Business Overview
      • 2.2. Company Snapshot
      • 2.3. Company Market Share Analysis
      • 2.4. Company Product Portfolio
      • 2.5. Recent Developments
      • 2.6. SWOT Analysis
    • EVOTEC
      • 3.1. Business Overview
      • 3.2. Company Snapshot
      • 3.3. Company Market Share Analysis
      • 3.4. Company Product Portfolio
      • 3.5. Recent Developments
      • 3.6. SWOT Analysis
    • Jubilant Biosys
      • 4.1. Business Overview
      • 4.2. Company Snapshot
      • 4.3. Company Market Share Analysis
      • 4.4. Company Product Portfolio
      • 4.5. Recent Developments
      • 4.6. SWOT Analysis
    • GenScript
      • 5.1. Business Overview
      • 5.2. Company Snapshot
      • 5.3. Company Market Share Analysis
      • 5.4. Company Product Portfolio
      • 5.5. Recent Developments
      • 5.6. SWOT Analysis
    • Pharmaceutical Product Development, LLC
      • 6.1. Business Overview
      • 6.2. Company Snapshot
      • 6.3. Company Market Share Analysis
      • 6.4. Company Product Portfolio
      • 6.5. Recent Developments
      • 6.6. SWOT Analysis
    • Charles River
      • 7.1. Business Overview
      • 7.2. Company Snapshot
      • 7.3. Company Market Share Analysis
      • 7.4. Company Product Portfolio
      • 7.5. Recent Developments
      • 7.6. SWOT Analysis
    • Laboratory Corporation of America Holdings
      • 8.1. Business Overview
      • 8.2. Company Snapshot
      • 8.3. Company Market Share Analysis
      • 8.4. Company Product Portfolio
      • 8.5. Recent Developments
      • 8.6. SWOT Analysis
    • Merck & Co., Inc.
      • 9.1. Business Overview
      • 9.2. Company Snapshot
      • 9.3. Company Market Share Analysis
      • 9.4. Company Product Portfolio
      • 9.5. Recent Developments
      • 9.6. SWOT Analysis
    • Thermo Fisher Scientific Inc.
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Product Portfolio
      • Recent Developments
      • SWOT Analysis

List of Table

1. Global Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
2. Global Small Molecules, Drug Discovery Outsourcing Market, By Region, 2021–2029 (USD Billion)
3. Global Large Molecules, Drug Discovery Outsourcing Market, By Region, 2021–2029 (USD Billion)
4. Global Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
5. Global Respiratory System, Drug Discovery Outsourcing Market, By Region, 2021–2029 (USD Billion)
6. Global Oncology, Drug Discovery Outsourcing Market, By Region, 2021–2029 (USD Billion)
7. Global Immunomodulation, Drug Discovery Outsourcing Market, By Region, 2021–2029 (USD Billion)
8. Global Others, Drug Discovery Outsourcing Market, By Region, 2021–2029 (USD Billion)
9. Global Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
10. Global Target Identification & Screening, Drug Discovery Outsourcing Market, By Region, 2021–2029 (USD Billion)
11. Global Target Validation & Functional Informatics, Drug Discovery Outsourcing Market, By Region, 2021–2029 (USD Billion)
12. Global Lead Identification & Candidate Optimization, Drug Discovery Outsourcing Market, By Region, 2021–2029 (USD Billion)
13. Global Others, Drug Discovery Outsourcing Market, By Region, 2021–2029 (USD Billion)
14. Global Drug Discovery Outsourcing Market, By Region, 2021–2029 (USD Billion)
15. North America Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
16. North America Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
17. North America Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
18. USA Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
19. USA Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
20. USA Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)  
21. Canada Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
22. Canada Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
23. Canada Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
24. Mexico Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
25. Mexico Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
26. Mexico Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
27. Europe Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
28. Europe Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
29. Europe Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
30. Germany Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
31. Germany Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
32. Germany Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
33. France Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
34. France Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
35. France Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
36. UK Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
37. UK Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
38. UK Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
39. Italy Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
40. Italy Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
41. Italy Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
42. Spain Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
43. Spain Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
44. Spain Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
45. Asia Pacific Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
46. Asia Pacific Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
47. Asia Pacific Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
48. Japan Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
49. Japan Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
50. Japan Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
51. China Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
52. China Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
53. China Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
54. India Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
55. India Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
56. India Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
57. South America Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
58. South America Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
59. South America Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
60. Brazil Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
61. Brazil Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
62. Brazil Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
63. Middle East and Africa Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
64. Middle East and Africa Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
65. Middle East and Africa Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
66. UAE Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
67. UAE Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
68. UAE Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)
69. South Africa Drug Discovery Outsourcing Market, By Drug Type, 2021–2029 (USD Billion)
70. South Africa Drug Discovery Outsourcing Market, By Therapeutic Area, 2021–2029 (USD Billion)
71. South Africa Drug Discovery Outsourcing Market, By Workflow, 2021–2029 (USD Billion)

List of Figures 

1. Global Drug Discovery Outsourcing Market Segmentation
2. Drug Discovery Outsourcing Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Drug Discovery Outsourcing Market Attractiveness Analysis By Drug Type
9. Global Drug Discovery Outsourcing Market Attractiveness Analysis By Therapeutic Area
10. Global Drug Discovery Outsourcing Market Attractiveness Analysis By Workflow
11. Global Drug Discovery Outsourcing Market Attractiveness Analysis By Region
12. Global Drug Discovery Outsourcing Market: Dynamics
13. Global Drug Discovery Outsourcing Market Share By Drug Type (2021 & 2029)
14. Global Drug Discovery Outsourcing Market Share By Therapeutic Area (2021 & 2029)
15. Global Drug Discovery Outsourcing Market Share By Workflow (2021 & 2029)
16. Global Drug Discovery Outsourcing Market Share by Regions (2021 & 2029)
17. Global Drug Discovery Outsourcing Market Share by Company (2020)